SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,231,850 | -25.6% | 355,000 | -0.4% | 0.01% | -28.6% |
| Q2 2023 | $1,656,795 | +3.6% | 356,300 | +3.0% | 0.01% | -6.7% |
| Q1 2023 | $1,598,501 | -30.3% | 345,996 | +21.9% | 0.02% | -21.1% |
| Q4 2022 | $2,293,104 | +765.3% | 283,800 | +493.7% | 0.02% | +850.0% |
| Q3 2022 | $265,000 | -22.1% | 47,800 | -26.8% | 0.00% | -33.3% |
| Q2 2022 | $340,000 | -79.2% | 65,300 | -8.8% | 0.00% | -85.0% |
| Q1 2021 | $1,631,000 | -45.3% | 71,614 | -47.8% | 0.02% | -50.0% |
| Q4 2020 | $2,979,000 | +481.8% | 137,227 | +169.1% | 0.04% | +300.0% |
| Q3 2020 | $512,000 | – | 51,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |